Monitoring cell‐mediated immunity during immunosuppression reduction in heart transplant recipients with severe systemic infections
- 31 January 2020
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 34 (3) , e13809
Abstract
Background: Treatment for severe systemic infections in heart transplantation is reduction in immunosuppression while treating the infection. An assay that measures adenosine triphosphate production in activated lymphocytes (ImmuKnow®) objectively monitors cellular immunity of transplant recipients. In this study, we used ImmuKnow®to adjust immunosuppression in heart transplant recipients with severe systemic infections.Methods: Heart transplant recipients were followed with ImmuKnow®at the time of biopsy and diagnosis of systemic infection. Patients who developed an infection were monitored by ImmuKnow®assay with adjustments in immunosuppression based upon the results of the assay. Maintenance immunosuppression was reinstituted when the ImmuKnow®increased to >225 ng/mL of ATP.Results: Two or more ImmuKnow®assays were performed in 80 patients. Thirteen patients developed severe systemic infections. ImmuKnow®mean value at the time of diagnosis of infection was 109 ± 49.2 ng/mL. Reduction in immunosuppression and treatment of infection resulted in normalization of ImmuKnow®level, resolution of infection, and no episodes of rebound rejection.Conclusion: Heart transplant recipients with severe systemic infections presented with a decreased ImmuKnow®, suggesting over immunosuppression. ImmuKnow®can be used as an objective measurement in withdrawing immunosuppression in heart transplant recipients with severe systemic infections.Keywords
This publication has 29 references indexed in Scilit:
- IFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1PLOS ONE, 2013
- Individualized Immune Monitoring of Cardiac Transplant Recipients by Noninvasive Longitudinal Cellular Immunity TestsTransplantation, 2010
- Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With InfectionTransplantation, 2009
- Cylex ImmuKnow Assay Levels Are Lower in Lung Transplant Recipients With InfectionThe Journal of Heart and Lung Transplantation, 2008
- Utility of the Cylex Assay in Cardiac Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2008
- Immunodiagnostics: Evaluation of Functional T-Cell Immunocompetence in Whole Blood Independent of Circulating Cell NumbersJournal of Immunotoxicology, 2007
- Pancreas Transplantation Under Alemtuzumab (Campath-1H) and Tacrolimus: Correlation Between Low T-Cell Responses and InfectionTransplantation, 2006
- Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high‐risk for EBV infectionClinical Transplantation, 2006
- Immunosuppression: evolution in practice and trends, 1993–2003American Journal of Transplantation, 2005
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991